about
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients.Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives.Involvement of miRNA in erythroid differentiation.Recent trends in the gene therapy of β-thalassemia.Erythroid differentiation ability of butyric acid analogues: identification of basal chemical structures of new inducers of foetal haemoglobin.Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients.Erythroid induction of chronic myelogenous leukemia K562 cells following treatment with a photoproduct derived from the UV-A irradiation of 5-methoxypsoralen.Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs.Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproductsBergamot (Citrus bergamia Risso) fruit extracts as γ-globin gene expression inducers: phytochemical and functional perspectives.Induction of gamma-globin mRNA, erythroid differentiation and apoptosis in UVA-irradiated human erythroid cells in the presence of furocumarin derivatives.Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.Preparation and biological evaluation of some 1,2-O-isopropylidene-D-hexofuranose esters.A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassaemia mutation for the screening of correctors of stop-codon mutations.Tobramycin is a suppressor of premature termination codons.Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia.Everolimus is a potent inducer of erythroid differentiation and gamma-globin gene expression in human erythroid cells.Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients.Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future ExpectationsA Novel Frameshift Mutation (+A) at Codon 18 of the β-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and δβ-ThalassemiaEffects on erythroid differentiation of platinum(II) complexes of synthetic bile acid derivatives
P50
Q35301892-F4D04400-BC16-486D-9BDD-3761F47DEC74Q36611332-F3357477-5A6D-4854-A343-8E024913B674Q37309900-45750A30-36CF-41D6-B6C6-F08C0302CC24Q37590391-6F036D24-31A6-41FE-99F1-0D03D3E626CDQ37983889-D504FF00-34D5-4380-BC78-2E3A5B23F929Q38367473-42455A0B-55D2-44E0-8256-ADF009859168Q38907520-881C6BFB-37D2-455A-A4E2-688C55463223Q39388051-3A8ACAC5-C0C8-4DF7-832C-A3F0AE0D6D77Q39678044-32425286-FAE0-43CD-9C77-9C2852075B38Q39795854-239876BD-3D44-40E5-9134-719DC5E6DB07Q39814424-736252FA-23C1-474A-B326-5A24A3D9354FQ39860344-F6F5AE94-2291-4C2B-BC15-8ACDA555245CQ40049519-108FC8EF-B822-4EC9-866C-F66D145901ACQ40746113-1D421079-460E-4732-A9F9-473552ED1B03Q42167068-DD42F657-F337-4944-A274-5658A3B7F36CQ42224585-C696C4B3-6EA1-4D38-BDF5-ADAC2FB31023Q43239262-E14975B2-78E9-4789-A6E4-154A569B8FAEQ44509426-FE81E023-CB69-4A74-A6A5-9CC68E2BF215Q45888439-25F94864-863E-4A69-A73C-98CB6C2BAA67Q54568641-CAF67424-B909-494D-8EAA-8201291D771EQ54585312-E209916A-91A1-4F66-9271-22CC161D37EBQ54585888-CB24156E-DA75-4A4B-997D-E0C78683AE4EQ54586430-5BA58BE7-6DE0-4138-90DA-1F4BCF7A1A00Q60583220-1410BF91-338B-4C50-B974-CA97B3BA10D5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cristina Zuccato
@ast
Cristina Zuccato
@en
Cristina Zuccato
@es
Cristina Zuccato
@nl
Cristina Zuccato
@sl
type
label
Cristina Zuccato
@ast
Cristina Zuccato
@en
Cristina Zuccato
@es
Cristina Zuccato
@nl
Cristina Zuccato
@sl
prefLabel
Cristina Zuccato
@ast
Cristina Zuccato
@en
Cristina Zuccato
@es
Cristina Zuccato
@nl
Cristina Zuccato
@sl
P1053
L-2919-2015
P106
P1153
12144254900
P21
P31
P3829
P496
0000-0002-1380-0539